Stockreport

InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent [Yahoo! Finance]

InspireMD Inc.  (NSPR) 
NASDAQ:AMEX Investor Relations: inspiremd.com/en/investors/investor-relations
PDF InspireMD 's NSPR recently announced that the FDA has granted investigational device exemption (IDE) or premarket approval for its CGuard Prime 80cm carotid stent syste [Read more]